Anna Borodovsky

Examiner
DISC Type : sc

Vice President, Research at Alnylam Pharmaceuticals

Cambridge, Massachusetts, United States

Overview

Anna Borodovsky is the Vice President of Research at Alnylam Pharmaceuticals, where she has worked since 2006. With a PhD from Harvard University, she leads the companys preclinical liver pipeline, playing a key role in the development of several RNAi therapeutic programs from target nomination to first-in-human studies.

Anna is passionate about the real-world impact of her work, expressing great satisfaction in seeing therapies reach patients. She takes pleasure in supporting patient communities, particularly for conditions like Huntingtons Disease, and celebrates drug approvals that improve the lives of those with neurological and rare diseases.

She has been involved with some research programs, like cemdisiran, for over a decade, from initial stages to successful Phase 3 data.

Personality Overview

Late Adopter

Unexpressive

Overcautious

They do not like taking risks at all and go for proven options in the end.  They are heavily focused on quality and prefer doing things the right way, even if it takes time. The only way to convince them is by showing them examples and ample proof.

Topics They Care About

RNAi Therapeutics
Leads the preclinical development of RNAi therapeutics and is a named inventor on numerous patents for novel RNAi agents and compositions for various diseases.
Drug Development
Her career has spanned the full drug development lifecycle, from discovery and preclinical work on programs like inclisiran and cemdisiran to seeing them reach clinical success.
Neurological Diseases
Expresses pride in bringing RNAi therapeutics to neurological conditions and actively supports the Huntington's Disease community.

Media Appearances

Anna has no verified media appearances

Work History

2-2023
Vice President, Research at Alnylam Pharmaceuticals
4-2021 - 2-2023
Senior Director, Research at Alnylam Pharmaceuticals
1-2019 - 4-2021
Director, Research at Alnylam Pharmaceuticals
1-2017 - 12-2018
Associate Director at Alnylam Pharmaceuticals
1-2012 - 12-2016
Principal Scientist at Alnylam Pharmaceuticals

Education

BS from Emory University
PhD from Harvard University

More Information

Social Presence :

Prographics :

Exp : 23 Location : Cambridge, Massachusetts, United States Job Level : Senior Designation : Vice President, Research at Alnylam Pharmaceuticals
URL has been copied!

Insights For Selling To Anna

During A Call Or A Meeting

DO's

  • Be firm in your communication and stay in control
  • Ask them which other stakeholders would be important for this purchase decision
  • Expect them to be vague in response to your questions, ask firmly and pointedly

DONT's

  • Don't rely on relationship building even if they act pleasantly
  • Don't use phrases like 'do not worry', 'i promise' etc.
  • Don't be very accepting if that is your natural style, stay firm

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Anna is

  • Proof of usage by others in the industry, case studies showing ROI are likely to work the best with them.
  • Will you ever get a clear answer from Anna

  • They don’t say no often, they push out the decisions or keep going around in circles.

Insights For Deal Planning

    How fast (or slow) will Anna move?

  • They are some of the slowest movers and take their time reaching decisions.
  • Can Anna take some risk or not?

  • They have very low acceptance of risk even if they do not say it directly.

You And Anna

Personality Compatibility


Other Alnylam Pharmaceuticals Employees

Explore more public profiles from related professionals at the same organization.

More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.